LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
26 funds hold it · Insiders net selling
Net selling: insiders sold $1.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 27, 2026
Financial period
2026 third quarter
Earnings per share
$2.30 expected
Revenue
$3.79B expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 27, 2026 | $2.67est. $2.30 | +15.90%beat | $4.01Best. $3.79B+5.79% | -21.4%from $5.11B |
| Jun 30, 2026Reported Jul 28, 2026 | $2.56est. $2.46 | +3.99%beat | $4.67BSEC filing | -10.5%from $5.21B |
| Mar 31, 2026Reported Apr 28, 2026 | $2.50est. $2.46 | +1.47%beat | $4.52BSEC filing | -3.3%from $4.67B |
| Dec 31, 2025Reported Feb 9, 2026 | $2.98est. $2.57 | +15.83%beat | $4.93BSEC filing | -1.7%from $5.02B |
| Sep 30, 2025Reported Oct 27, 2025 | $2.77est. $2.25 | +23.11%beat | $5.11BSEC filing | +8.2%from $4.72B |
| Jun 30, 2025Reported Jul 29, 2025 | $2.58est. $2.30 | +12.17%beat | $5.21BSEC filing | +23.3%from $4.23B |
| Mar 31, 2025Reported Apr 29, 2025 | $1.54est. $1.31 | +17.56%beat | $4.67BSEC filing | +18.6%from $3.94B |
| Dec 31, 2024Reported Feb 10, 2025 | $2.26est. $1.80 | +25.56%beat | $5.02BAlpha Vantage | +32.6%from $3.79B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.39B | $4.36B | $4.47B | $4.66B |
| Cost of what it sold | $3.06B | $2.09B | $2.20B | $2.21B |
| Gross profit | $2.33B | $2.27B | $2.28B | $2.45B |
| What it spent | ||||
| Sales and admin | $79.0M | — | — | $477.0M |
| Other operating costs | $862.0M | $1.13B | $1.05B | $742.0M |
| Total operating expenses | $941.0M | $1.13B | $1.05B | $1.22B |
| What was left | ||||
| Operating profit | $1.39B | $1.15B | $1.22B | $1.23B |
| Interest on debt | $38.0M | $37.0M | $44.0M | $62.0M |
| Profit before tax | $1.45B | $1.15B | $1.22B | $1.19B |
| Tax | $210.0M | $98.0M | $164.0M | $184.0M |
| Net profit | $1.24B | $1.05B | $1.06B | $1.03B |
| EBITDA | $1.50B | $1.21B | $1.29B | $1.28B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Everest Group (EG) Faces Securities Class Action, Is The Stock Fully Valued?
NeutralNov 10Shareholders may resell Arch Capital (ACGL) shares; the company gets none of those proceeds.
NeutralNov 10Insurity (Decisions Suite) and Insurity (Pro Suite) Recognized in 2026 Gartner® Magic Quadrant™ for SaaS P&C Insurance Core Platforms, North America
Leans bullishNov 10ACGL Stock Gains 19.5% in a Year: Here's What Investors Should Know?
BullishNov 10Arch Insurance appoints two senior property and casualty underwriters in UK Regional Division
BullishNov 10ARCH CAPITAL GROUP 5.45% NON CUM DEP REP 1/1000 PFD SER F To Go Ex-Dividend On December 15th, 2026 With 0.34063 USD Dividend Per Share
Leans bullishNov 10At $15 a share, ARCH funds buy into the Aspen Neuroscience (ASPE) IPO.
Leans bullishNov 9Discipline and Rules-Based Execution in ACGLO Response
NeutralNov 9
